東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Drug Evaluation, Preclinical." ]

切換: 標籤 | MARC模式 | ISBD

The process of new drug discovery an...

O'Donnell, James, (Pharm. D.)

FindBook

Google Book

Amazon

博客來

The process of new drug discovery and development

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	The process of new drug discovery and development / editors, Charles G. Smith and James O'Donnell.
其他作者:	O'Donnell, James,
出版者:	Boca Raton :Taylor & Francis, : c2006.,
面頁冊數:	p. ;cm.
附註:	Rev. ed. of: The process of new drug discovery and development / Charles G. Smith. c1992.
內容註:	Overview of the process of new drug discovery and development / by Charles G. Smith and James T. O'Donnell -- Integrated product development: from lead candidate selection to life-cycle management/ by Madhu Pudipeddi, Abu T.M. Serajuddin, and Daniel Mufson -- Combinatorial chemistry / by Michael H. Rabinowitz and Nigel Shankley -- High-throughput screening: enabling and influencing the process of drug discovery/ by Carol Ann Homon and Richard M. Nelson -- Pharmacological and pharmaceutical profiling: new trends -- Cell-based analysis of drug response using moving optical gradient fields / by Jeff M. Hall ... [et al.] --
內容註:	Patient-derived primary cells in high-throughput differential anti-tumor screens: let the patients be the guide/ by Irwin Braude -- The evolving role of the caco-2 cell model to estimate intestinal absorption potential and elucidate transport mechanisms / by Jibin Li and Ismael J. Hidalgo --
內容註:	The promise of metabonomics in drug discovery / by Harold J. Kwalwasser and Pauline Gee -- Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-druSafe workshop/ by Lawrence J. Lesko ... [et al.] -- Drugs from molecular targets for CNS and neurodegenerative diseases / by William T. Comer and Gonul Velicelebi -- Safety pharmacology / by Jean-Pierre Valentin -- Nonclinical drug safety assessment/ by Frederick E. Reno -- Preclinical genotoxicity testing: past, present and future / by Richard H.C. San -- The need for animals in biomedical research / by Charles G. Smith -- Defining the actual research approach to the new drug substance/ by Charles G. Smith -- A. Good pharmacokinetic practice to streamline new drug development, B. pharmacokinetic/pharmacodynamic modeling in new drug development / by Sarfaraz K. Niazi --
內容註:	Pharmaceutics and compounding issues in new drug development and marketing / by Loyd V. Allen, Jr -- Late stage and process development activities / by Charles Smith -- Contract research organizations: role and function in new drug development/ by F. Richard Nichol, Jr. -- The front lines of clinical research: the industry / by Lori Nesbitt -- Horizons for cancer chemotherapy (and non-chemotherapy) / by Daniel D. Von Hoff -- Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) clinical testing challenges / by Vincent Idemyor -- CTD: the changing face of the NDA / by Justina Molzon -- Electronic publishing/ by Heather Leigh Wallace -- The important role of pharmacists in a complex risk management system: managing the risks from medical product use by focusing on patient education, monitoring, and adverse event reporting/ by Justina Molzon -- Liability, litigation, and lessons in new drug development / by James T. O'Donnell -- Problems in the non-drug marketplace/ by Stephen Barrett -- Patents and new product development in the pharmaceutical and biotechnology industries / by Henry Grabowski --
內容註:	The pharmaceutical revolution: drug discovery and development / by John C. Somberg -- The discovery of Rituxan / by Mitchell E. Reff -- Funding the birth of a drug: lessons from the "sell" side/ by Howard E. (Ted) Greene, Jr. -- Innovations for the drug development pathway: what is needed now/ Janet Woodcock -- A. Using dynamic modeling to assess and maximize commercial potential of developmental drug compounds, B. Risk assessment and addressing uncertainty in pharmaceutical new drug discovery and development / by Mark Paich ... [et al.].
標題:	Drugs - Design -
電子資源:	http://www.taebcnetbase.com/ejournals/books/book_km.asp?id=4790Click here for the electronic version
ISBN:	0849327792 (alk. paper)

The process of new drug discovery and development
The process of new drug discovery and development [electronic resource] /editors, Charles G. Smith and James O'Donnell. - 2nd ed. - Boca Raton :Taylor & Francis,c2006. - p. ;cm.

Rev. ed. of: The process of new drug discovery and development / Charles G. Smith. c1992.

Includes bibliographical references and index.

Overview of the process of new drug discovery and development / by Charles G. Smith and James T. O'Donnell -- Integrated product development: from lead candidate selection to life-cycle management/ by Madhu Pudipeddi, Abu T.M. Serajuddin, and Daniel Mufson -- Combinatorial chemistry / by Michael H. Rabinowitz and Nigel Shankley -- High-throughput screening: enabling and influencing the process of drug discovery/ by Carol Ann Homon and Richard M. Nelson -- Pharmacological and pharmaceutical profiling: new trends -- Cell-based analysis of drug response using moving optical gradient fields / by Jeff M. Hall ... [et al.] --

ISBN: 0849327792 (alk. paper)

LCCN: 2005036791Subjects--Topical Terms:

916391
Drugs
--Design

LC Class. No.: RM301.25 / .S55 2006

Dewey Class. No.: 615/.19

National Library of Medicine Call No.: QV 744 / P9645 2006

The process of new drug discovery and development
LDR:05138cam a2200433 a 45 001 778086
005 20081028
006 m d
007 cr cn ---ancau
008 081028s2006 flu sb 001 0 eng
010 $a 2005036791
020 $a 0849327792 (alk. paper)
020 $a 9780849327797 (alk. paper)
035 $a (DNLM)101263798
035 $a 14207733
040 $a DNLM/DLC $c DLC $d DLC
042 $a pcc
050 0 0 $a RM301.25 $b .S55 2006
060 1 0 $a QV 744 $b P9645 2006
082 0 0 $a 615/.19 $2 22
245 0 4 $a The process of new drug discovery and development $h [electronic resource] / $c editors, Charles G. Smith and James O'Donnell.
250 $a 2nd ed.
260 $a Boca Raton : $c c2006. $b Taylor & Francis,
263 $a 0606
300 $a p. ; $c cm.
500 $a Rev. ed. of: The process of new drug discovery and development / Charles G. Smith. c1992.
504 $a Includes bibliographical references and index.
505 0 $a Overview of the process of new drug discovery and development / by Charles G. Smith and James T. O'Donnell -- Integrated product development: from lead candidate selection to life-cycle management/ by Madhu Pudipeddi, Abu T.M. Serajuddin, and Daniel Mufson -- Combinatorial chemistry / by Michael H. Rabinowitz and Nigel Shankley -- High-throughput screening: enabling and influencing the process of drug discovery/ by Carol Ann Homon and Richard M. Nelson -- Pharmacological and pharmaceutical profiling: new trends -- Cell-based analysis of drug response using moving optical gradient fields / by Jeff M. Hall ... [et al.] --
505 0 $a Patient-derived primary cells in high-throughput differential anti-tumor screens: let the patients be the guide/ by Irwin Braude -- The evolving role of the caco-2 cell model to estimate intestinal absorption potential and elucidate transport mechanisms / by Jibin Li and Ismael J. Hidalgo --
505 0 $a The promise of metabonomics in drug discovery / by Harold J. Kwalwasser and Pauline Gee -- Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-druSafe workshop/ by Lawrence J. Lesko ... [et al.] -- Drugs from molecular targets for CNS and neurodegenerative diseases / by William T. Comer and Gonul Velicelebi -- Safety pharmacology / by Jean-Pierre Valentin -- Nonclinical drug safety assessment/ by Frederick E. Reno -- Preclinical genotoxicity testing: past, present and future / by Richard H.C. San -- The need for animals in biomedical research / by Charles G. Smith -- Defining the actual research approach to the new drug substance/ by Charles G. Smith -- A. Good pharmacokinetic practice to streamline new drug development, B. pharmacokinetic/pharmacodynamic modeling in new drug development / by Sarfaraz K. Niazi --
505 0 $a Pharmaceutics and compounding issues in new drug development and marketing / by Loyd V. Allen, Jr -- Late stage and process development activities / by Charles Smith -- Contract research organizations: role and function in new drug development/ by F. Richard Nichol, Jr. -- The front lines of clinical research: the industry / by Lori Nesbitt -- Horizons for cancer chemotherapy (and non-chemotherapy) / by Daniel D. Von Hoff -- Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) clinical testing challenges / by Vincent Idemyor -- CTD: the changing face of the NDA / by Justina Molzon -- Electronic publishing/ by Heather Leigh Wallace -- The important role of pharmacists in a complex risk management system: managing the risks from medical product use by focusing on patient education, monitoring, and adverse event reporting/ by Justina Molzon -- Liability, litigation, and lessons in new drug development / by James T. O'Donnell -- Problems in the non-drug marketplace/ by Stephen Barrett -- Patents and new product development in the pharmaceutical and biotechnology industries / by Henry Grabowski --
505 0 $a The pharmaceutical revolution: drug discovery and development / by John C. Somberg -- The discovery of Rituxan / by Mitchell E. Reff -- Funding the birth of a drug: lessons from the "sell" side/ by Howard E. (Ted) Greene, Jr. -- Innovations for the drug development pathway: what is needed now/ Janet Woodcock -- A. Using dynamic modeling to assess and maximize commercial potential of developmental drug compounds, B. Risk assessment and addressing uncertainty in pharmaceutical new drug discovery and development / by Mark Paich ... [et al.].
650 $a Drugs $x Design $x History. $3 916391
650 $a Drugs $x Research $x History. $3 682600
650 $a Drug Design. $3 550958
650 $a Drug Evaluation, Preclinical. $3 752567
650 $a Drug Evaluation. $3 550959
700 $a O'Donnell, James, $c Pharm. D. $3 916389
700 $a Smith, Charles G. $q (Charles Giles) $3 916390
856 4 0 $3 CRCnetBASE $u http://www.taebcnetbase.com/ejournals/books/book_km.asp?id=4790 $z Click here for the electronic version
906 $a 7 $b rix $c orignew $d 1 $e ecip $f 20 $g y-gencatlg
925 0 $a acquire $b 1 shelf copy $x policy default
952 $a Prev. ed.: LCCN 92-13558
952 $a TO LC: Add related work a.e.: 700 1 Smith, Charles G. (Charles Giles). #t The process of new drug discovery and development.
955 $d jc18 2005-12-22 $e jc18 2005-12-22 to Dewey $a aa27 2005-12-27
963 $a Elise M. Oranges; phone: 561-994-0555; email: Elise.Oranges@taylorandfrancis.com; bc: jamie.gorham@taylorandfrancis.com
985 $a NLMCIP $d 2005-12-22